Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6417857
[patent_doc_number] => 20100167326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'METHOD FOR CLEAVAGE OF PEPTIDIC BOND AT C TERMINAL OF PEPTIDE AND A METHOD FOR DETERMINATION OF C TERMINAL AMINO ACID SEQUENCE OF PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/278878
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10310
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278878 | METHOD FOR CLEAVAGE OF PEPTIDIC BOND AT C TERMINAL OF PEPTIDE AND A METHOD FOR DETERMINATION OF C TERMINAL AMINO ACID SEQUENCE OF PEPTIDE | Feb 7, 2007 | Abandoned |
Array
(
[id] => 10857763
[patent_doc_number] => 08883965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/223654
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3327
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223654 | Compounds | Feb 4, 2007 | Issued |
Array
(
[id] => 5514778
[patent_doc_number] => 20090215085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential'
[patent_app_type] => utility
[patent_app_number] => 12/162471
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15986
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162471 | Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential | Jan 28, 2007 | Abandoned |
Array
(
[id] => 5285403
[patent_doc_number] => 20090099078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Nogo Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/162256
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 65160
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099078.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162256 | Nogo receptor antagonists | Jan 25, 2007 | Issued |
Array
(
[id] => 4826829
[patent_doc_number] => 20080125373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'MNTF peptides and compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/657815
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10530
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11657815
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/657815 | MNTF peptides and compositions and methods of use | Jan 24, 2007 | Issued |
Array
(
[id] => 5367135
[patent_doc_number] => 20090304694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Ang2 and Vegf Inhibitor Combinations'
[patent_app_type] => utility
[patent_app_number] => 12/223003
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22843
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304694.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223003
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223003 | Ang2 and Vegf Inhibitor Combinations | Jan 18, 2007 | Abandoned |
Array
(
[id] => 111916
[patent_doc_number] => 07718617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Methods for preserving organs and tissues'
[patent_app_type] => utility
[patent_app_number] => 11/621246
[patent_app_country] => US
[patent_app_date] => 2007-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11433
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11621246
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/621246 | Methods for preserving organs and tissues | Jan 8, 2007 | Issued |
Array
(
[id] => 5070173
[patent_doc_number] => 20070191275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments'
[patent_app_type] => utility
[patent_app_number] => 11/649889
[patent_app_country] => US
[patent_app_date] => 2007-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8229
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11649889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/649889 | Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments | Jan 4, 2007 | Abandoned |
Array
(
[id] => 9944418
[patent_doc_number] => 08993719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Methods and compositions related to mutant Kunitz domain I of TFPI-2'
[patent_app_type] => utility
[patent_app_number] => 12/087296
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 14481
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12087296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/087296 | Methods and compositions related to mutant Kunitz domain I of TFPI-2 | Dec 28, 2006 | Issued |
Array
(
[id] => 142396
[patent_doc_number] => 07691964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Peptide anti-tumor agent'
[patent_app_type] => utility
[patent_app_number] => 11/615723
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8624
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11615723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/615723 | Peptide anti-tumor agent | Dec 21, 2006 | Issued |
Array
(
[id] => 5397310
[patent_doc_number] => 20090317373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Inhibition of the Anti-FVIII Immune Response'
[patent_app_type] => utility
[patent_app_number] => 12/086851
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7238
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317373.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086851 | Inhibition of the Anti-FVIII Immune Response | Dec 21, 2006 | Abandoned |
Array
(
[id] => 6589670
[patent_doc_number] => 20100130432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Non-Natural Amino Acids and Neurotensin Analogues Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/086528
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 42733
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086528
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086528 | Non-Natural Amino Acids and Neurotensin Analogues Thereof | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5136461
[patent_doc_number] => 20070078090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'ANTI-CHRONDROSARCOMA COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/609816
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19627
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11609816
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/609816 | Anti-chrondrosarcoma compounds | Dec 11, 2006 | Issued |
Array
(
[id] => 5035282
[patent_doc_number] => 20070099821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => ' METHOD OF ACTIVATING INSULIN RECEPTOR SUBSTRATE-2 TO STIMULATE INSULIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 11/609530
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11046
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11609530
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/609530 | METHOD OF ACTIVATING INSULIN RECEPTOR SUBSTRATE-2 TO STIMULATE INSULIN PRODUCTION | Dec 11, 2006 | Abandoned |
Array
(
[id] => 7740558
[patent_doc_number] => 08106016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => 'Compounds and compositions for prevention of overdose of oxycodone'
[patent_app_type] => utility
[patent_app_number] => 11/635788
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 12709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/106/08106016.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635788 | Compounds and compositions for prevention of overdose of oxycodone | Dec 7, 2006 | Issued |
Array
(
[id] => 5219311
[patent_doc_number] => 20070160622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Method for assembling a polymer-biologic delivery composition'
[patent_app_type] => utility
[patent_app_number] => 11/636230
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31407
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160622.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636230 | Method for assembling a polymer-biologic delivery composition | Dec 6, 2006 | Abandoned |
Array
(
[id] => 5130715
[patent_doc_number] => 20070207112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Anti-acne composition'
[patent_app_type] => utility
[patent_app_number] => 11/634368
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4086
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207112.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634368 | Anti-acne composition | Dec 4, 2006 | Abandoned |
Array
(
[id] => 5160404
[patent_doc_number] => 20070173448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'SOLUTION FOR REMOVING CATARACTS VIA LIQUEFRACTURE'
[patent_app_type] => utility
[patent_app_number] => 11/565256
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3885
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565256 | SOLUTION FOR REMOVING CATARACTS VIA LIQUEFRACTURE | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5172370
[patent_doc_number] => 20070072803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level'
[patent_app_type] => utility
[patent_app_number] => 11/603410
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 77278
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603410 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Nov 21, 2006 | Issued |
Array
(
[id] => 5172371
[patent_doc_number] => 20070072804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level'
[patent_app_type] => utility
[patent_app_number] => 11/603417
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 77229
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072804.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603417 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Nov 21, 2006 | Issued |